nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—HTR7—coronary artery disease	0.199	0.665	CbGaD
Maprotiline—HTR2A—coronary artery disease	0.1	0.335	CbGaD
Maprotiline—ORM1—Penbutolol—coronary artery disease	0.0614	0.162	CbGbCtD
Maprotiline—ORM1—Pitavastatin—coronary artery disease	0.0537	0.141	CbGbCtD
Maprotiline—ABCB1—Ticagrelor—coronary artery disease	0.0219	0.0576	CbGbCtD
Maprotiline—CYP1A2—Gemfibrozil—coronary artery disease	0.0178	0.047	CbGbCtD
Maprotiline—CYP1A2—Clopidogrel—coronary artery disease	0.0155	0.0407	CbGbCtD
Maprotiline—ABCB1—Clopidogrel—coronary artery disease	0.0135	0.0356	CbGbCtD
Maprotiline—ABCB1—Perindopril—coronary artery disease	0.0135	0.0356	CbGbCtD
Maprotiline—ABCB1—Pitavastatin—coronary artery disease	0.0118	0.0311	CbGbCtD
Maprotiline—ABCB1—Telmisartan—coronary artery disease	0.0118	0.0311	CbGbCtD
Maprotiline—ABCB1—Enalapril—coronary artery disease	0.0112	0.0295	CbGbCtD
Maprotiline—ABCB1—Lisinopril—coronary artery disease	0.0112	0.0295	CbGbCtD
Maprotiline—CYP2D6—Niacin—coronary artery disease	0.00966	0.0254	CbGbCtD
Maprotiline—ABCB1—Timolol—coronary artery disease	0.00953	0.0251	CbGbCtD
Maprotiline—CYP2D6—Timolol—coronary artery disease	0.00898	0.0236	CbGbCtD
Maprotiline—ABCB1—Ezetimibe—coronary artery disease	0.00871	0.0229	CbGbCtD
Maprotiline—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00849	0.0224	CbGbCtD
Maprotiline—ABCB1—Captopril—coronary artery disease	0.00839	0.0221	CbGbCtD
Maprotiline—ABCB1—Simvastatin—coronary artery disease	0.0081	0.0213	CbGbCtD
Maprotiline—ABCB1—Lovastatin—coronary artery disease	0.00793	0.0209	CbGbCtD
Maprotiline—ABCB1—Pravastatin—coronary artery disease	0.00793	0.0209	CbGbCtD
Maprotiline—CYP2D6—Captopril—coronary artery disease	0.0079	0.0208	CbGbCtD
Maprotiline—CYP2D6—Simvastatin—coronary artery disease	0.00763	0.0201	CbGbCtD
Maprotiline—CYP1A2—Losartan—coronary artery disease	0.00755	0.0199	CbGbCtD
Maprotiline—CYP2D6—Pravastatin—coronary artery disease	0.00747	0.0197	CbGbCtD
Maprotiline—CYP2D6—Lovastatin—coronary artery disease	0.00747	0.0197	CbGbCtD
Maprotiline—ABCB1—Atorvastatin—coronary artery disease	0.00722	0.019	CbGbCtD
Maprotiline—CYP2D6—Atorvastatin—coronary artery disease	0.0068	0.0179	CbGbCtD
Maprotiline—ABCB1—Losartan—coronary artery disease	0.0066	0.0174	CbGbCtD
Maprotiline—SLC6A2—sympathetic nervous system—coronary artery disease	0.00295	0.0805	CbGeAlD
Maprotiline—HTR7—pulmonary artery—coronary artery disease	0.00292	0.0797	CbGeAlD
Maprotiline—HTR7—sympathetic nervous system—coronary artery disease	0.00284	0.0776	CbGeAlD
Maprotiline—HTR2A—arteriole—coronary artery disease	0.00278	0.0759	CbGeAlD
Maprotiline—HTR7—vagus nerve—coronary artery disease	0.00275	0.0751	CbGeAlD
Maprotiline—HTR7—vein—coronary artery disease	0.00266	0.0726	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—coronary artery disease	0.00198	0.0541	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—coronary artery disease	0.00191	0.0521	CbGeAlD
Maprotiline—HTR2A—pulmonary artery—coronary artery disease	0.00182	0.0497	CbGeAlD
Maprotiline—HTR2A—sympathetic nervous system—coronary artery disease	0.00177	0.0484	CbGeAlD
Maprotiline—HTR2A—vagus nerve—coronary artery disease	0.00172	0.0468	CbGeAlD
Maprotiline—HTR2A—vein—coronary artery disease	0.00166	0.0453	CbGeAlD
Maprotiline—HTR2A—autonomic nervous system—coronary artery disease	0.00119	0.0325	CbGeAlD
Maprotiline—HTR7—artery—coronary artery disease	0.00108	0.0296	CbGeAlD
Maprotiline—HTR7—endothelium—coronary artery disease	0.000914	0.025	CbGeAlD
Maprotiline—HTR2A—artery—coronary artery disease	0.000675	0.0184	CbGeAlD
Maprotiline—HTR2A—endothelium—coronary artery disease	0.00057	0.0156	CbGeAlD
Maprotiline—CHRM2—heart—coronary artery disease	0.000514	0.014	CbGeAlD
Maprotiline—CHRM2—cardiovascular system—coronary artery disease	0.000485	0.0133	CbGeAlD
Maprotiline—Sertraline—CYP2C19—coronary artery disease	0.00047	0.241	CrCbGaD
Maprotiline—CHRM1—cardiovascular system—coronary artery disease	0.000442	0.0121	CbGeAlD
Maprotiline—ORM1—blood—coronary artery disease	0.000411	0.0112	CbGeAlD
Maprotiline—HTR7—heart—coronary artery disease	0.000399	0.0109	CbGeAlD
Maprotiline—HTR7—cardiovascular system—coronary artery disease	0.000376	0.0103	CbGeAlD
Maprotiline—HTR7—blood—coronary artery disease	0.000297	0.00813	CbGeAlD
Maprotiline—HTR2A—heart—coronary artery disease	0.000249	0.00679	CbGeAlD
Maprotiline—CYP1A2—blood—coronary artery disease	0.000237	0.00648	CbGeAlD
Maprotiline—HTR2A—cardiovascular system—coronary artery disease	0.000235	0.00641	CbGeAlD
Maprotiline—Desipramine—SLC22A3—coronary artery disease	0.000216	0.111	CrCbGaD
Maprotiline—HTR2A—blood—coronary artery disease	0.000186	0.00507	CbGeAlD
Maprotiline—Imipramine—SLC22A3—coronary artery disease	0.000183	0.0942	CrCbGaD
Maprotiline—CYP2D6—blood—coronary artery disease	0.000169	0.00462	CbGeAlD
Maprotiline—ABCB1—heart—coronary artery disease	0.000163	0.00445	CbGeAlD
Maprotiline—ABCB1—cardiovascular system—coronary artery disease	0.000154	0.0042	CbGeAlD
Maprotiline—ABCB1—blood—coronary artery disease	0.000122	0.00332	CbGeAlD
Maprotiline—Atomoxetine—CYP2C19—coronary artery disease	0.000118	0.0608	CrCbGaD
Maprotiline—Desipramine—ADRB1—coronary artery disease	0.000118	0.0604	CrCbGaD
Maprotiline—Imipramine—HTR7—coronary artery disease	0.000116	0.0598	CrCbGaD
Maprotiline—Nortriptyline—CYP2C19—coronary artery disease	0.000103	0.0531	CrCbGaD
Maprotiline—Desipramine—ADRB2—coronary artery disease	9.9e-05	0.0508	CrCbGaD
Maprotiline—Atomoxetine—HTR2A—coronary artery disease	9.6e-05	0.0493	CrCbGaD
Maprotiline—Desipramine—CYP2C19—coronary artery disease	8.52e-05	0.0437	CrCbGaD
Maprotiline—Nortriptyline—HTR2A—coronary artery disease	8.39e-05	0.0431	CrCbGaD
Maprotiline—Imipramine—CYP2C19—coronary artery disease	7.22e-05	0.0371	CrCbGaD
Maprotiline—Desipramine—HTR2A—coronary artery disease	6.91e-05	0.0355	CrCbGaD
Maprotiline—Anxiety—Ramipril—coronary artery disease	6.55e-05	0.000374	CcSEcCtD
Maprotiline—Vomiting—Lovastatin—coronary artery disease	6.54e-05	0.000373	CcSEcCtD
Maprotiline—Somnolence—Losartan—coronary artery disease	6.54e-05	0.000373	CcSEcCtD
Maprotiline—Dizziness—Eplerenone—coronary artery disease	6.53e-05	0.000373	CcSEcCtD
Maprotiline—Rash—Clopidogrel—coronary artery disease	6.53e-05	0.000373	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	6.53e-05	0.000372	CcSEcCtD
Maprotiline—Dermatitis—Clopidogrel—coronary artery disease	6.53e-05	0.000372	CcSEcCtD
Maprotiline—Asthenia—Valsartan—coronary artery disease	6.52e-05	0.000372	CcSEcCtD
Maprotiline—Hypertension—Timolol—coronary artery disease	6.52e-05	0.000372	CcSEcCtD
Maprotiline—Constipation—Furosemide—coronary artery disease	6.52e-05	0.000372	CcSEcCtD
Maprotiline—Asthenia—Olmesartan—coronary artery disease	6.49e-05	0.00037	CcSEcCtD
Maprotiline—Headache—Clopidogrel—coronary artery disease	6.49e-05	0.00037	CcSEcCtD
Maprotiline—Rash—Lovastatin—coronary artery disease	6.49e-05	0.00037	CcSEcCtD
Maprotiline—Dermatitis—Lovastatin—coronary artery disease	6.48e-05	0.00037	CcSEcCtD
Maprotiline—Dyspepsia—Losartan—coronary artery disease	6.47e-05	0.000369	CcSEcCtD
Maprotiline—Feeling abnormal—Perindopril—coronary artery disease	6.46e-05	0.000368	CcSEcCtD
Maprotiline—Headache—Lovastatin—coronary artery disease	6.45e-05	0.000368	CcSEcCtD
Maprotiline—Pruritus—Valsartan—coronary artery disease	6.43e-05	0.000367	CcSEcCtD
Maprotiline—Dry mouth—Ramipril—coronary artery disease	6.43e-05	0.000367	CcSEcCtD
Maprotiline—Vomiting—Ezetimibe—coronary artery disease	6.42e-05	0.000366	CcSEcCtD
Maprotiline—Gastrointestinal pain—Perindopril—coronary artery disease	6.41e-05	0.000366	CcSEcCtD
Maprotiline—Anxiety—Timolol—coronary artery disease	6.41e-05	0.000365	CcSEcCtD
Maprotiline—Pruritus—Olmesartan—coronary artery disease	6.4e-05	0.000365	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.39e-05	0.000364	CcSEcCtD
Maprotiline—Body temperature increased—Captopril—coronary artery disease	6.38e-05	0.000364	CcSEcCtD
Maprotiline—Abdominal pain—Captopril—coronary artery disease	6.38e-05	0.000364	CcSEcCtD
Maprotiline—Dizziness—Simvastatin—coronary artery disease	6.37e-05	0.000363	CcSEcCtD
Maprotiline—Rash—Ezetimibe—coronary artery disease	6.37e-05	0.000363	CcSEcCtD
Maprotiline—Dermatitis—Ezetimibe—coronary artery disease	6.36e-05	0.000363	CcSEcCtD
Maprotiline—Confusional state—Ramipril—coronary artery disease	6.36e-05	0.000363	CcSEcCtD
Maprotiline—Asthenia—Niacin—coronary artery disease	6.34e-05	0.000362	CcSEcCtD
Maprotiline—Fatigue—Losartan—coronary artery disease	6.34e-05	0.000361	CcSEcCtD
Maprotiline—Headache—Ezetimibe—coronary artery disease	6.32e-05	0.000361	CcSEcCtD
Maprotiline—Oedema—Ramipril—coronary artery disease	6.31e-05	0.00036	CcSEcCtD
Maprotiline—Dry mouth—Timolol—coronary artery disease	6.29e-05	0.000359	CcSEcCtD
Maprotiline—Constipation—Losartan—coronary artery disease	6.29e-05	0.000359	CcSEcCtD
Maprotiline—Syncope—Lisinopril—coronary artery disease	6.28e-05	0.000358	CcSEcCtD
Maprotiline—Vomiting—Eplerenone—coronary artery disease	6.28e-05	0.000358	CcSEcCtD
Maprotiline—Feeling abnormal—Furosemide—coronary artery disease	6.28e-05	0.000358	CcSEcCtD
Maprotiline—Leukopenia—Lisinopril—coronary artery disease	6.27e-05	0.000358	CcSEcCtD
Maprotiline—Nausea—Fenofibrate—coronary artery disease	6.26e-05	0.000357	CcSEcCtD
Maprotiline—Pruritus—Niacin—coronary artery disease	6.25e-05	0.000357	CcSEcCtD
Maprotiline—Asthenia—Pravastatin—coronary artery disease	6.25e-05	0.000356	CcSEcCtD
Maprotiline—Gastrointestinal pain—Furosemide—coronary artery disease	6.23e-05	0.000355	CcSEcCtD
Maprotiline—Rash—Eplerenone—coronary artery disease	6.23e-05	0.000355	CcSEcCtD
Maprotiline—Urticaria—Perindopril—coronary artery disease	6.23e-05	0.000355	CcSEcCtD
Maprotiline—Dermatitis—Eplerenone—coronary artery disease	6.22e-05	0.000355	CcSEcCtD
Maprotiline—Diarrhoea—Valsartan—coronary artery disease	6.22e-05	0.000355	CcSEcCtD
Maprotiline—Confusional state—Timolol—coronary artery disease	6.22e-05	0.000354	CcSEcCtD
Maprotiline—Shock—Ramipril—coronary artery disease	6.2e-05	0.000354	CcSEcCtD
Maprotiline—Abdominal pain—Perindopril—coronary artery disease	6.2e-05	0.000353	CcSEcCtD
Maprotiline—Body temperature increased—Perindopril—coronary artery disease	6.2e-05	0.000353	CcSEcCtD
Maprotiline—Palpitations—Lisinopril—coronary artery disease	6.19e-05	0.000353	CcSEcCtD
Maprotiline—Diarrhoea—Olmesartan—coronary artery disease	6.19e-05	0.000353	CcSEcCtD
Maprotiline—Headache—Eplerenone—coronary artery disease	6.19e-05	0.000353	CcSEcCtD
Maprotiline—Nervous system disorder—Ramipril—coronary artery disease	6.18e-05	0.000353	CcSEcCtD
Maprotiline—Thrombocytopenia—Ramipril—coronary artery disease	6.17e-05	0.000352	CcSEcCtD
Maprotiline—Oedema—Timolol—coronary artery disease	6.16e-05	0.000351	CcSEcCtD
Maprotiline—Pruritus—Pravastatin—coronary artery disease	6.16e-05	0.000351	CcSEcCtD
Maprotiline—Loss of consciousness—Lisinopril—coronary artery disease	6.16e-05	0.000351	CcSEcCtD
Maprotiline—Nausea—Clopidogrel—coronary artery disease	6.15e-05	0.000351	CcSEcCtD
Maprotiline—Tachycardia—Ramipril—coronary artery disease	6.15e-05	0.000351	CcSEcCtD
Maprotiline—Skin disorder—Ramipril—coronary artery disease	6.12e-05	0.000349	CcSEcCtD
Maprotiline—Infection—Timolol—coronary artery disease	6.12e-05	0.000349	CcSEcCtD
Maprotiline—Vomiting—Simvastatin—coronary artery disease	6.12e-05	0.000349	CcSEcCtD
Maprotiline—Nausea—Lovastatin—coronary artery disease	6.11e-05	0.000349	CcSEcCtD
Maprotiline—Hyperhidrosis—Ramipril—coronary artery disease	6.1e-05	0.000348	CcSEcCtD
Maprotiline—Rash—Simvastatin—coronary artery disease	6.07e-05	0.000346	CcSEcCtD
Maprotiline—Dermatitis—Simvastatin—coronary artery disease	6.06e-05	0.000346	CcSEcCtD
Maprotiline—Asthenia—Trandolapril—coronary artery disease	6.06e-05	0.000346	CcSEcCtD
Maprotiline—Shock—Timolol—coronary artery disease	6.06e-05	0.000346	CcSEcCtD
Maprotiline—Feeling abnormal—Losartan—coronary artery disease	6.06e-05	0.000346	CcSEcCtD
Maprotiline—Urticaria—Furosemide—coronary artery disease	6.05e-05	0.000345	CcSEcCtD
Maprotiline—Diarrhoea—Niacin—coronary artery disease	6.05e-05	0.000345	CcSEcCtD
Maprotiline—Nervous system disorder—Timolol—coronary artery disease	6.05e-05	0.000345	CcSEcCtD
Maprotiline—Asthenia—Enalapril—coronary artery disease	6.04e-05	0.000344	CcSEcCtD
Maprotiline—Headache—Simvastatin—coronary artery disease	6.03e-05	0.000344	CcSEcCtD
Maprotiline—Body temperature increased—Furosemide—coronary artery disease	6.02e-05	0.000344	CcSEcCtD
Maprotiline—Abdominal pain—Furosemide—coronary artery disease	6.02e-05	0.000344	CcSEcCtD
Maprotiline—Gastrointestinal pain—Losartan—coronary artery disease	6.01e-05	0.000343	CcSEcCtD
Maprotiline—Dizziness—Valsartan—coronary artery disease	6.01e-05	0.000343	CcSEcCtD
Maprotiline—Nausea—Ezetimibe—coronary artery disease	6e-05	0.000342	CcSEcCtD
Maprotiline—Skin disorder—Timolol—coronary artery disease	5.99e-05	0.000341	CcSEcCtD
Maprotiline—Dizziness—Olmesartan—coronary artery disease	5.98e-05	0.000341	CcSEcCtD
Maprotiline—Pruritus—Trandolapril—coronary artery disease	5.98e-05	0.000341	CcSEcCtD
Maprotiline—Hyperhidrosis—Timolol—coronary artery disease	5.96e-05	0.00034	CcSEcCtD
Maprotiline—Asthenia—Telmisartan—coronary artery disease	5.96e-05	0.00034	CcSEcCtD
Maprotiline—Pruritus—Enalapril—coronary artery disease	5.96e-05	0.00034	CcSEcCtD
Maprotiline—Diarrhoea—Pravastatin—coronary artery disease	5.96e-05	0.00034	CcSEcCtD
Maprotiline—Anxiety—Lisinopril—coronary artery disease	5.94e-05	0.000339	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.92e-05	0.000338	CcSEcCtD
Maprotiline—Hypotension—Ramipril—coronary artery disease	5.89e-05	0.000336	CcSEcCtD
Maprotiline—Pruritus—Telmisartan—coronary artery disease	5.87e-05	0.000335	CcSEcCtD
Maprotiline—Nausea—Eplerenone—coronary artery disease	5.87e-05	0.000335	CcSEcCtD
Maprotiline—Imipramine—HTR2A—coronary artery disease	5.86e-05	0.0301	CrCbGaD
Maprotiline—Dizziness—Niacin—coronary artery disease	5.85e-05	0.000333	CcSEcCtD
Maprotiline—Urticaria—Losartan—coronary artery disease	5.84e-05	0.000333	CcSEcCtD
Maprotiline—Dry mouth—Lisinopril—coronary artery disease	5.83e-05	0.000333	CcSEcCtD
Maprotiline—Abdominal pain—Losartan—coronary artery disease	5.81e-05	0.000331	CcSEcCtD
Maprotiline—Body temperature increased—Losartan—coronary artery disease	5.81e-05	0.000331	CcSEcCtD
Maprotiline—Asthenia—Captopril—coronary artery disease	5.79e-05	0.00033	CcSEcCtD
Maprotiline—Diarrhoea—Trandolapril—coronary artery disease	5.78e-05	0.00033	CcSEcCtD
Maprotiline—Vomiting—Valsartan—coronary artery disease	5.78e-05	0.00033	CcSEcCtD
Maprotiline—Confusional state—Lisinopril—coronary artery disease	5.77e-05	0.000329	CcSEcCtD
Maprotiline—Diarrhoea—Enalapril—coronary artery disease	5.76e-05	0.000328	CcSEcCtD
Maprotiline—Hypotension—Timolol—coronary artery disease	5.76e-05	0.000328	CcSEcCtD
Maprotiline—Dizziness—Pravastatin—coronary artery disease	5.76e-05	0.000328	CcSEcCtD
Maprotiline—Vomiting—Olmesartan—coronary artery disease	5.75e-05	0.000328	CcSEcCtD
Maprotiline—Nortriptyline—ALB—coronary artery disease	5.74e-05	0.0295	CrCbGaD
Maprotiline—Rash—Valsartan—coronary artery disease	5.73e-05	0.000327	CcSEcCtD
Maprotiline—Dermatitis—Valsartan—coronary artery disease	5.73e-05	0.000327	CcSEcCtD
Maprotiline—Nausea—Simvastatin—coronary artery disease	5.72e-05	0.000326	CcSEcCtD
Maprotiline—Oedema—Lisinopril—coronary artery disease	5.72e-05	0.000326	CcSEcCtD
Maprotiline—Pruritus—Captopril—coronary artery disease	5.71e-05	0.000326	CcSEcCtD
Maprotiline—Rash—Olmesartan—coronary artery disease	5.71e-05	0.000325	CcSEcCtD
Maprotiline—Insomnia—Ramipril—coronary artery disease	5.7e-05	0.000325	CcSEcCtD
Maprotiline—Dermatitis—Olmesartan—coronary artery disease	5.7e-05	0.000325	CcSEcCtD
Maprotiline—Headache—Valsartan—coronary artery disease	5.7e-05	0.000325	CcSEcCtD
Maprotiline—Diarrhoea—Telmisartan—coronary artery disease	5.68e-05	0.000324	CcSEcCtD
Maprotiline—Infection—Lisinopril—coronary artery disease	5.68e-05	0.000324	CcSEcCtD
Maprotiline—Headache—Olmesartan—coronary artery disease	5.67e-05	0.000323	CcSEcCtD
Maprotiline—Paraesthesia—Ramipril—coronary artery disease	5.66e-05	0.000323	CcSEcCtD
Maprotiline—Shock—Lisinopril—coronary artery disease	5.63e-05	0.000321	CcSEcCtD
Maprotiline—Asthenia—Perindopril—coronary artery disease	5.62e-05	0.000321	CcSEcCtD
Maprotiline—Vomiting—Niacin—coronary artery disease	5.62e-05	0.00032	CcSEcCtD
Maprotiline—Somnolence—Ramipril—coronary artery disease	5.61e-05	0.00032	CcSEcCtD
Maprotiline—Thrombocytopenia—Lisinopril—coronary artery disease	5.6e-05	0.000319	CcSEcCtD
Maprotiline—Dizziness—Trandolapril—coronary artery disease	5.59e-05	0.000319	CcSEcCtD
Maprotiline—Tachycardia—Lisinopril—coronary artery disease	5.58e-05	0.000318	CcSEcCtD
Maprotiline—Insomnia—Timolol—coronary artery disease	5.58e-05	0.000318	CcSEcCtD
Maprotiline—Rash—Niacin—coronary artery disease	5.57e-05	0.000318	CcSEcCtD
Maprotiline—Dermatitis—Niacin—coronary artery disease	5.57e-05	0.000318	CcSEcCtD
Maprotiline—Dizziness—Enalapril—coronary artery disease	5.57e-05	0.000317	CcSEcCtD
Maprotiline—Skin disorder—Lisinopril—coronary artery disease	5.55e-05	0.000317	CcSEcCtD
Maprotiline—Dyspepsia—Ramipril—coronary artery disease	5.55e-05	0.000316	CcSEcCtD
Maprotiline—Pruritus—Perindopril—coronary artery disease	5.55e-05	0.000316	CcSEcCtD
Maprotiline—Headache—Niacin—coronary artery disease	5.54e-05	0.000316	CcSEcCtD
Maprotiline—Paraesthesia—Timolol—coronary artery disease	5.54e-05	0.000316	CcSEcCtD
Maprotiline—Vomiting—Pravastatin—coronary artery disease	5.53e-05	0.000316	CcSEcCtD
Maprotiline—Hyperhidrosis—Lisinopril—coronary artery disease	5.53e-05	0.000315	CcSEcCtD
Maprotiline—Diarrhoea—Captopril—coronary artery disease	5.52e-05	0.000315	CcSEcCtD
Maprotiline—Dizziness—Telmisartan—coronary artery disease	5.49e-05	0.000313	CcSEcCtD
Maprotiline—Rash—Pravastatin—coronary artery disease	5.49e-05	0.000313	CcSEcCtD
Maprotiline—Dermatitis—Pravastatin—coronary artery disease	5.48e-05	0.000313	CcSEcCtD
Maprotiline—Somnolence—Timolol—coronary artery disease	5.48e-05	0.000312	CcSEcCtD
Maprotiline—Asthenia—Furosemide—coronary artery disease	5.47e-05	0.000312	CcSEcCtD
Maprotiline—Headache—Pravastatin—coronary artery disease	5.45e-05	0.000311	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Ramipril—coronary artery disease	5.44e-05	0.00031	CcSEcCtD
Maprotiline—Fatigue—Ramipril—coronary artery disease	5.44e-05	0.00031	CcSEcCtD
Maprotiline—Dyspepsia—Timolol—coronary artery disease	5.43e-05	0.000309	CcSEcCtD
Maprotiline—Nausea—Valsartan—coronary artery disease	5.4e-05	0.000308	CcSEcCtD
Maprotiline—Pruritus—Furosemide—coronary artery disease	5.39e-05	0.000307	CcSEcCtD
Maprotiline—Constipation—Ramipril—coronary artery disease	5.39e-05	0.000307	CcSEcCtD
Maprotiline—Nausea—Olmesartan—coronary artery disease	5.37e-05	0.000306	CcSEcCtD
Maprotiline—Vomiting—Trandolapril—coronary artery disease	5.37e-05	0.000306	CcSEcCtD
Maprotiline—Diarrhoea—Perindopril—coronary artery disease	5.36e-05	0.000306	CcSEcCtD
Maprotiline—Vomiting—Enalapril—coronary artery disease	5.35e-05	0.000305	CcSEcCtD
Maprotiline—Hypotension—Lisinopril—coronary artery disease	5.34e-05	0.000305	CcSEcCtD
Maprotiline—Dizziness—Captopril—coronary artery disease	5.34e-05	0.000304	CcSEcCtD
Maprotiline—Rash—Trandolapril—coronary artery disease	5.33e-05	0.000304	CcSEcCtD
Maprotiline—Dermatitis—Trandolapril—coronary artery disease	5.32e-05	0.000304	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Timolol—coronary artery disease	5.32e-05	0.000303	CcSEcCtD
Maprotiline—Fatigue—Timolol—coronary artery disease	5.31e-05	0.000303	CcSEcCtD
Maprotiline—Rash—Enalapril—coronary artery disease	5.31e-05	0.000303	CcSEcCtD
Maprotiline—Dermatitis—Enalapril—coronary artery disease	5.3e-05	0.000302	CcSEcCtD
Maprotiline—Headache—Trandolapril—coronary artery disease	5.3e-05	0.000302	CcSEcCtD
Maprotiline—Vomiting—Telmisartan—coronary artery disease	5.28e-05	0.000301	CcSEcCtD
Maprotiline—Asthenia—Losartan—coronary artery disease	5.28e-05	0.000301	CcSEcCtD
Maprotiline—Headache—Enalapril—coronary artery disease	5.27e-05	0.000301	CcSEcCtD
Maprotiline—Nausea—Niacin—coronary artery disease	5.25e-05	0.000299	CcSEcCtD
Maprotiline—Rash—Telmisartan—coronary artery disease	5.24e-05	0.000299	CcSEcCtD
Maprotiline—Dermatitis—Telmisartan—coronary artery disease	5.23e-05	0.000298	CcSEcCtD
Maprotiline—Diarrhoea—Furosemide—coronary artery disease	5.21e-05	0.000297	CcSEcCtD
Maprotiline—Pruritus—Losartan—coronary artery disease	5.2e-05	0.000297	CcSEcCtD
Maprotiline—Headache—Telmisartan—coronary artery disease	5.2e-05	0.000297	CcSEcCtD
Maprotiline—Feeling abnormal—Ramipril—coronary artery disease	5.2e-05	0.000296	CcSEcCtD
Maprotiline—Dizziness—Perindopril—coronary artery disease	5.18e-05	0.000296	CcSEcCtD
Maprotiline—Insomnia—Lisinopril—coronary artery disease	5.17e-05	0.000295	CcSEcCtD
Maprotiline—Nausea—Pravastatin—coronary artery disease	5.17e-05	0.000295	CcSEcCtD
Maprotiline—Gastrointestinal pain—Ramipril—coronary artery disease	5.16e-05	0.000294	CcSEcCtD
Maprotiline—Paraesthesia—Lisinopril—coronary artery disease	5.13e-05	0.000293	CcSEcCtD
Maprotiline—Vomiting—Captopril—coronary artery disease	5.13e-05	0.000293	CcSEcCtD
Maprotiline—Rash—Captopril—coronary artery disease	5.09e-05	0.00029	CcSEcCtD
Maprotiline—Dermatitis—Captopril—coronary artery disease	5.09e-05	0.00029	CcSEcCtD
Maprotiline—Somnolence—Lisinopril—coronary artery disease	5.08e-05	0.00029	CcSEcCtD
Maprotiline—Feeling abnormal—Timolol—coronary artery disease	5.08e-05	0.00029	CcSEcCtD
Maprotiline—Headache—Captopril—coronary artery disease	5.06e-05	0.000288	CcSEcCtD
Maprotiline—Gastrointestinal pain—Timolol—coronary artery disease	5.04e-05	0.000287	CcSEcCtD
Maprotiline—Dizziness—Furosemide—coronary artery disease	5.04e-05	0.000287	CcSEcCtD
Maprotiline—Dyspepsia—Lisinopril—coronary artery disease	5.03e-05	0.000287	CcSEcCtD
Maprotiline—Diarrhoea—Losartan—coronary artery disease	5.03e-05	0.000287	CcSEcCtD
Maprotiline—Nausea—Trandolapril—coronary artery disease	5.02e-05	0.000286	CcSEcCtD
Maprotiline—Urticaria—Ramipril—coronary artery disease	5.01e-05	0.000286	CcSEcCtD
Maprotiline—Nausea—Enalapril—coronary artery disease	5e-05	0.000285	CcSEcCtD
Maprotiline—Vomiting—Perindopril—coronary artery disease	4.98e-05	0.000284	CcSEcCtD
Maprotiline—Abdominal pain—Ramipril—coronary artery disease	4.98e-05	0.000284	CcSEcCtD
Maprotiline—Body temperature increased—Ramipril—coronary artery disease	4.98e-05	0.000284	CcSEcCtD
Maprotiline—Rash—Perindopril—coronary artery disease	4.94e-05	0.000282	CcSEcCtD
Maprotiline—Dermatitis—Perindopril—coronary artery disease	4.94e-05	0.000282	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.94e-05	0.000281	CcSEcCtD
Maprotiline—Nausea—Telmisartan—coronary artery disease	4.93e-05	0.000281	CcSEcCtD
Maprotiline—Fatigue—Lisinopril—coronary artery disease	4.93e-05	0.000281	CcSEcCtD
Maprotiline—Headache—Perindopril—coronary artery disease	4.91e-05	0.00028	CcSEcCtD
Maprotiline—Urticaria—Timolol—coronary artery disease	4.9e-05	0.000279	CcSEcCtD
Maprotiline—Constipation—Lisinopril—coronary artery disease	4.89e-05	0.000279	CcSEcCtD
Maprotiline—Abdominal pain—Timolol—coronary artery disease	4.87e-05	0.000278	CcSEcCtD
Maprotiline—Body temperature increased—Timolol—coronary artery disease	4.87e-05	0.000278	CcSEcCtD
Maprotiline—Dizziness—Losartan—coronary artery disease	4.86e-05	0.000277	CcSEcCtD
Maprotiline—Vomiting—Furosemide—coronary artery disease	4.85e-05	0.000276	CcSEcCtD
Maprotiline—Rash—Furosemide—coronary artery disease	4.81e-05	0.000274	CcSEcCtD
Maprotiline—Dermatitis—Furosemide—coronary artery disease	4.8e-05	0.000274	CcSEcCtD
Maprotiline—Nausea—Captopril—coronary artery disease	4.8e-05	0.000273	CcSEcCtD
Maprotiline—Headache—Furosemide—coronary artery disease	4.77e-05	0.000272	CcSEcCtD
Maprotiline—Feeling abnormal—Lisinopril—coronary artery disease	4.71e-05	0.000269	CcSEcCtD
Maprotiline—Gastrointestinal pain—Lisinopril—coronary artery disease	4.68e-05	0.000267	CcSEcCtD
Maprotiline—Vomiting—Losartan—coronary artery disease	4.68e-05	0.000267	CcSEcCtD
Maprotiline—Nausea—Perindopril—coronary artery disease	4.66e-05	0.000266	CcSEcCtD
Maprotiline—Rash—Losartan—coronary artery disease	4.64e-05	0.000264	CcSEcCtD
Maprotiline—Dermatitis—Losartan—coronary artery disease	4.63e-05	0.000264	CcSEcCtD
Maprotiline—Headache—Losartan—coronary artery disease	4.61e-05	0.000263	CcSEcCtD
Maprotiline—Urticaria—Lisinopril—coronary artery disease	4.54e-05	0.000259	CcSEcCtD
Maprotiline—Nausea—Furosemide—coronary artery disease	4.53e-05	0.000258	CcSEcCtD
Maprotiline—Asthenia—Ramipril—coronary artery disease	4.52e-05	0.000258	CcSEcCtD
Maprotiline—Body temperature increased—Lisinopril—coronary artery disease	4.52e-05	0.000258	CcSEcCtD
Maprotiline—Abdominal pain—Lisinopril—coronary artery disease	4.52e-05	0.000258	CcSEcCtD
Maprotiline—Pruritus—Ramipril—coronary artery disease	4.46e-05	0.000254	CcSEcCtD
Maprotiline—Asthenia—Timolol—coronary artery disease	4.42e-05	0.000252	CcSEcCtD
Maprotiline—Nausea—Losartan—coronary artery disease	4.37e-05	0.000249	CcSEcCtD
Maprotiline—Pruritus—Timolol—coronary artery disease	4.36e-05	0.000249	CcSEcCtD
Maprotiline—Diarrhoea—Ramipril—coronary artery disease	4.31e-05	0.000246	CcSEcCtD
Maprotiline—Diarrhoea—Timolol—coronary artery disease	4.22e-05	0.00024	CcSEcCtD
Maprotiline—Dizziness—Ramipril—coronary artery disease	4.17e-05	0.000238	CcSEcCtD
Maprotiline—Asthenia—Lisinopril—coronary artery disease	4.1e-05	0.000234	CcSEcCtD
Maprotiline—Dizziness—Timolol—coronary artery disease	4.08e-05	0.000232	CcSEcCtD
Maprotiline—Pruritus—Lisinopril—coronary artery disease	4.05e-05	0.000231	CcSEcCtD
Maprotiline—Vomiting—Ramipril—coronary artery disease	4.01e-05	0.000229	CcSEcCtD
Maprotiline—Rash—Ramipril—coronary artery disease	3.98e-05	0.000227	CcSEcCtD
Maprotiline—Dermatitis—Ramipril—coronary artery disease	3.97e-05	0.000226	CcSEcCtD
Maprotiline—Headache—Ramipril—coronary artery disease	3.95e-05	0.000225	CcSEcCtD
Maprotiline—Vomiting—Timolol—coronary artery disease	3.92e-05	0.000223	CcSEcCtD
Maprotiline—Diarrhoea—Lisinopril—coronary artery disease	3.91e-05	0.000223	CcSEcCtD
Maprotiline—Rash—Timolol—coronary artery disease	3.89e-05	0.000222	CcSEcCtD
Maprotiline—Dermatitis—Timolol—coronary artery disease	3.88e-05	0.000221	CcSEcCtD
Maprotiline—Headache—Timolol—coronary artery disease	3.86e-05	0.00022	CcSEcCtD
Maprotiline—Dizziness—Lisinopril—coronary artery disease	3.78e-05	0.000216	CcSEcCtD
Maprotiline—Nausea—Ramipril—coronary artery disease	3.75e-05	0.000214	CcSEcCtD
Maprotiline—Nausea—Timolol—coronary artery disease	3.66e-05	0.000209	CcSEcCtD
Maprotiline—Vomiting—Lisinopril—coronary artery disease	3.64e-05	0.000207	CcSEcCtD
Maprotiline—Rash—Lisinopril—coronary artery disease	3.61e-05	0.000206	CcSEcCtD
Maprotiline—Dermatitis—Lisinopril—coronary artery disease	3.6e-05	0.000205	CcSEcCtD
Maprotiline—Headache—Lisinopril—coronary artery disease	3.58e-05	0.000204	CcSEcCtD
Maprotiline—Nausea—Lisinopril—coronary artery disease	3.4e-05	0.000194	CcSEcCtD
Maprotiline—DRD2—Signaling Pathways—GSK3B—coronary artery disease	2.01e-06	1.88e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GPX1—coronary artery disease	2e-06	1.87e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—FGF2—coronary artery disease	2e-06	1.86e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCND1—coronary artery disease	2e-06	1.86e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—POMC—coronary artery disease	2e-06	1.86e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CREB1—coronary artery disease	2e-06	1.86e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	1.98e-06	1.85e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GSK3B—coronary artery disease	1.98e-06	1.84e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOS3—coronary artery disease	1.97e-06	1.84e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.97e-06	1.84e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	1.97e-06	1.84e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AKT1—coronary artery disease	1.97e-06	1.83e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—POMC—coronary artery disease	1.97e-06	1.83e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CREB1—coronary artery disease	1.97e-06	1.83e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	1.96e-06	1.83e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—POMC—coronary artery disease	1.96e-06	1.83e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CREB1—coronary artery disease	1.96e-06	1.83e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—POMC—coronary artery disease	1.96e-06	1.82e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CREB1—coronary artery disease	1.96e-06	1.82e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL2—coronary artery disease	1.95e-06	1.82e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CD36—coronary artery disease	1.95e-06	1.82e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—POMC—coronary artery disease	1.95e-06	1.82e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CREB1—coronary artery disease	1.95e-06	1.82e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6R—coronary artery disease	1.95e-06	1.82e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	1.95e-06	1.81e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MMP9—coronary artery disease	1.94e-06	1.81e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—LPL—coronary artery disease	1.94e-06	1.8e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—coronary artery disease	1.93e-06	1.8e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CREB1—coronary artery disease	1.93e-06	1.8e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—coronary artery disease	1.93e-06	1.8e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.93e-06	1.79e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL2—coronary artery disease	1.92e-06	1.79e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1—coronary artery disease	1.92e-06	1.79e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL2—coronary artery disease	1.92e-06	1.79e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—JAK2—coronary artery disease	1.92e-06	1.79e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6R—coronary artery disease	1.92e-06	1.79e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6R—coronary artery disease	1.91e-06	1.78e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL2—coronary artery disease	1.91e-06	1.78e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	1.91e-06	1.78e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6R—coronary artery disease	1.91e-06	1.78e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL2—coronary artery disease	1.91e-06	1.78e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6R—coronary artery disease	1.9e-06	1.77e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1—coronary artery disease	1.89e-06	1.76e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL2—coronary artery disease	1.89e-06	1.76e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GPX1—coronary artery disease	1.89e-06	1.76e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1—coronary artery disease	1.89e-06	1.76e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	1.88e-06	1.76e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6R—coronary artery disease	1.88e-06	1.75e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	1.88e-06	1.75e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1—coronary artery disease	1.88e-06	1.75e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.88e-06	1.75e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	1.88e-06	1.75e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1—coronary artery disease	1.87e-06	1.75e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	1.87e-06	1.74e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	1.87e-06	1.74e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—coronary artery disease	1.86e-06	1.73e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1—coronary artery disease	1.86e-06	1.73e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—coronary artery disease	1.85e-06	1.72e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	1.85e-06	1.72e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CD36—coronary artery disease	1.84e-06	1.71e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.83e-06	1.7e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.82e-06	1.7e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—coronary artery disease	1.82e-06	1.7e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.82e-06	1.69e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.82e-06	1.69e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.8e-06	1.68e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.8e-06	1.67e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.8e-06	1.67e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.79e-06	1.67e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.79e-06	1.67e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	1.79e-06	1.67e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.79e-06	1.67e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	1.79e-06	1.66e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	1.78e-06	1.66e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	1.78e-06	1.66e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—coronary artery disease	1.77e-06	1.65e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CAT—coronary artery disease	1.77e-06	1.65e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.77e-06	1.65e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.77e-06	1.64e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	1.76e-06	1.64e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AGT—coronary artery disease	1.76e-06	1.64e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.75e-06	1.63e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	1.74e-06	1.63e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.74e-06	1.62e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.74e-06	1.62e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.74e-06	1.62e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK1—coronary artery disease	1.74e-06	1.62e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—FGF2—coronary artery disease	1.73e-06	1.62e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—FGF2—coronary artery disease	1.73e-06	1.61e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—FGF2—coronary artery disease	1.72e-06	1.61e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—coronary artery disease	1.72e-06	1.6e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOB—coronary artery disease	1.72e-06	1.6e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.71e-06	1.6e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—coronary artery disease	1.71e-06	1.59e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—FGF2—coronary artery disease	1.71e-06	1.59e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—coronary artery disease	1.71e-06	1.59e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOA1—coronary artery disease	1.7e-06	1.59e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—coronary artery disease	1.7e-06	1.58e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.69e-06	1.58e-05	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.69e-06	1.58e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—coronary artery disease	1.68e-06	1.57e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.68e-06	1.56e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	1.67e-06	1.56e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.67e-06	1.56e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.67e-06	1.55e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.67e-06	1.55e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.66e-06	1.55e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.66e-06	1.55e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—JAK2—coronary artery disease	1.66e-06	1.54e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AGT—coronary artery disease	1.66e-06	1.54e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—JAK2—coronary artery disease	1.65e-06	1.54e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	1.64e-06	1.53e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—LPL—coronary artery disease	1.64e-06	1.53e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—JAK2—coronary artery disease	1.64e-06	1.52e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.63e-06	1.52e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.63e-06	1.52e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.63e-06	1.52e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.62e-06	1.51e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—coronary artery disease	1.62e-06	1.51e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	1.62e-06	1.51e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOA1—coronary artery disease	1.6e-06	1.49e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.6e-06	1.49e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	1.6e-06	1.49e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GPX1—coronary artery disease	1.6e-06	1.49e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.58e-06	1.48e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	1.57e-06	1.46e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CD36—coronary artery disease	1.56e-06	1.45e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.55e-06	1.44e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.54e-06	1.43e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.54e-06	1.43e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.52e-06	1.42e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.52e-06	1.41e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	1.51e-06	1.41e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	1.51e-06	1.4e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	1.51e-06	1.4e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPARG—coronary artery disease	1.5e-06	1.4e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.49e-06	1.39e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.49e-06	1.39e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.48e-06	1.38e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—coronary artery disease	1.48e-06	1.38e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.48e-06	1.38e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.47e-06	1.37e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.47e-06	1.37e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.47e-06	1.37e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.46e-06	1.36e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	1.46e-06	1.36e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.46e-06	1.36e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.45e-06	1.35e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CASP3—coronary artery disease	1.45e-06	1.35e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.45e-06	1.35e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CASP3—coronary artery disease	1.44e-06	1.34e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.44e-06	1.34e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.44e-06	1.34e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.44e-06	1.34e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.44e-06	1.34e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—coronary artery disease	1.43e-06	1.34e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.43e-06	1.33e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	1.42e-06	1.33e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.42e-06	1.32e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.42e-06	1.32e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.42e-06	1.32e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.41e-06	1.32e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPARG—coronary artery disease	1.41e-06	1.32e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.41e-06	1.31e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCND1—coronary artery disease	1.4e-06	1.31e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AGT—coronary artery disease	1.4e-06	1.31e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.4e-06	1.3e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—coronary artery disease	1.39e-06	1.3e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.39e-06	1.3e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.38e-06	1.28e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—coronary artery disease	1.37e-06	1.28e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.37e-06	1.28e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.37e-06	1.27e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—coronary artery disease	1.36e-06	1.27e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	1.36e-06	1.27e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOA1—coronary artery disease	1.36e-06	1.27e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.36e-06	1.26e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.35e-06	1.26e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—coronary artery disease	1.35e-06	1.26e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—coronary artery disease	1.33e-06	1.24e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.33e-06	1.24e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.33e-06	1.24e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.33e-06	1.24e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	1.32e-06	1.23e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.31e-06	1.22e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.31e-06	1.22e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.3e-06	1.21e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—coronary artery disease	1.29e-06	1.2e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.28e-06	1.19e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—coronary artery disease	1.27e-06	1.18e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—coronary artery disease	1.26e-06	1.17e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.26e-06	1.17e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.24e-06	1.15e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.23e-06	1.15e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—coronary artery disease	1.23e-06	1.15e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.23e-06	1.14e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	1.22e-06	1.14e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—coronary artery disease	1.22e-06	1.13e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.21e-06	1.13e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—coronary artery disease	1.21e-06	1.12e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARG—coronary artery disease	1.2e-06	1.12e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—coronary artery disease	1.18e-06	1.1e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—coronary artery disease	1.18e-06	1.1e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—coronary artery disease	1.16e-06	1.08e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.15e-06	1.07e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PIK3CA—coronary artery disease	1.14e-06	1.07e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.13e-06	1.06e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.13e-06	1.05e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.13e-06	1.05e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.13e-06	1.05e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	1.12e-06	1.05e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—coronary artery disease	1.11e-06	1.04e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.11e-06	1.04e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.11e-06	1.04e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.11e-06	1.04e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	1.11e-06	1.03e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.11e-06	1.03e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.11e-06	1.03e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	1.1e-06	1.03e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.09e-06	1.02e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—coronary artery disease	1.08e-06	1e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—coronary artery disease	1.03e-06	9.59e-06	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—coronary artery disease	9.84e-07	9.16e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	9.8e-07	9.13e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	9.65e-07	8.98e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	9.63e-07	8.97e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	9.6e-07	8.94e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	9.56e-07	8.91e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	9.47e-07	8.82e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—coronary artery disease	9.42e-07	8.77e-06	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—coronary artery disease	9.34e-07	8.7e-06	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—coronary artery disease	9.08e-07	8.45e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—coronary artery disease	8.68e-07	8.09e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—coronary artery disease	8.54e-07	7.96e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—coronary artery disease	8.52e-07	7.94e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—coronary artery disease	8.5e-07	7.91e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—coronary artery disease	8.47e-07	7.89e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—coronary artery disease	8.39e-07	7.81e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—coronary artery disease	8.01e-07	7.46e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—coronary artery disease	7.88e-07	7.34e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—coronary artery disease	7.86e-07	7.32e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—coronary artery disease	7.84e-07	7.3e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—coronary artery disease	7.81e-07	7.28e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—coronary artery disease	7.74e-07	7.21e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.26e-07	6.76e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6.84e-07	6.37e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—coronary artery disease	5.93e-07	5.52e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3CA—coronary artery disease	5.79e-07	5.4e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—coronary artery disease	5.59e-07	5.2e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—coronary artery disease	4.73e-07	4.41e-06	CbGpPWpGaD
